Showing results (1891-1900 of 2,593) with videos related to
Sort By:
Pageof 260
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2013
Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanomaPaolo A Ascierto, David Minor, Antoni Ribas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2022
Prognostic Value of FLT3-Internal Tandem Duplication Residual Disease in Acute Myeloid LeukemiaTim Grob, Mathijs A Sanders, Christian M Vonk, et al.EFSA Journal. European Food Safety Authority|January 10, 2024
Safety evaluation of an extension of use of the food enzyme containing cellulase, endo-1,3(4)-β-glucanase and endo-1,4-β-xylanase from the non-genetically modified Trichoderma reesei strain AR-256, Claude Lambré, José Manuel Barat Baviera, et al.EFSA Journal. European Food Safety Authority|February 23, 2023
Safety evaluation of the food enzyme α-amylase from the genetically modified Bacillus subtilis strain AR-651, Claude Lambré, José Manuel Barat Baviera, et al.EFSA Journal. European Food Safety Authority|February 27, 2023
Safety evaluation of the food enzyme cyclomaltodextrin glucanotransferase from the non-genetically modified Anoxybacillus caldiproteolyticus strain TCM3-539, Claude Lambré, José Manuel Barat Baviera, et al.EFSA Journal. European Food Safety Authority|January 21, 2022
Safety evaluation of the food enzyme trypsin from porcine pancreas, Claude Lambré, José Manuel Barat Baviera, et al.EFSA Journal. European Food Safety Authority|July 7, 2020
Safety evaluation of the food enzyme α,α-trehalase glucohydrolase from Trichoderma reesei (strain DP-Nzs51), Vittorio Silano, José Manuel Barat Baviera, et al.European Journal of Dermatology : EJD|January 31, 2019
Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE studyJohan Hansson, Karen Bartley, Thomas Karagiannis, et al.Journal of the American Academy of Dermatology|December 21, 2022
Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohortPerrine Rousset, Stéphane Dalle, Laurent Mortier, et al.EFSA Journal. European Food Safety Authority|October 9, 2023
Safety evaluation of the food enzyme glucose oxidase from the genetically modified Saccharomyces cerevisiae strain LALL-GO, Claude Lambré, José Manuel Barat Baviera, et al.Pageof 260